🇺🇸 FDA
Patent

US 6387389

Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use

expired A61KA61K31/495A61P

Quick answer

US patent 6387389 (Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/495, A61P, A61P25/30, A61P43/00